Additionally, during previous studies, follitropin delta was associated with a significantly lower incidence of OHSS than that associated with other rFSH preparations [17,18]. However, in those studies, no OHSS cases were observed, likely because of the inclusion of patients with AMH levels ≤2.03 ng/mL. Here, AMH is linked to ovarian hyperstimulation syndrome.